Chronic Kidney Disease: Navigating COVID-19 Vaccines (Austin)

Chronic Kidney Disease: Navigating COVID-19 Vaccines

Wednesday, April 12, 2023 | 7:00 PM - 9:00 PM

Thank you for attending this symposium. You are not required to complete this evaluation to earn CME/CE credit/contact hours for this symposium. However, your feedback is important to us, and your responses will assist us in developing future programs.

After attending this symposium, the participants in this educational activity will be able to:

Plan strategies to adopt guidelines and best practices for preventing SARS-CoV-2 infection for individuals with CKD during the evolving pandemic
Evaluate the efficacy, safety, and practical use of SARS-CoV-2 vaccines to prevent/lessen the effects of COVID in individuals with CKD
Interpret the clinical significance of emerging data regarding novel COVID-19 vaccinations and boosters

Supporter
This activity is supported by an educational grant from Moderna.

Evaluation for Chronic Kidney Disease: Navigating COVID-19 Vaccines

Name *

First

Last

Email *

Which social determinant of health (SDoH) do you most commonly see among your patients? Select one only. *

In your estimate, what percentage of your patients has the SDoH you selected that impacts your treatment decisions? *

Less than 25%
26% to 50%
51% to 75%
More than 75%

Rate your agreement with the following statement: *

	Strongly Disagree	Disagree	Neutral	Agree	Strongly Agree
My confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity	Strongly DisagreeMy confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity Strongly Disagree	DisagreeMy confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity Disagree	NeutralMy confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity Neutral	AgreeMy confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity Agree	Strongly AgreeMy confidence regarding the efficacy and safety of COVID-19 vaccinations and boosters in individuals with CKD has improved as a result of my participation in this activity Strongly Agree

How often did you implement the following strategies BEFORE participating in this activity? (select all that apply) *

	Never	Infrequently	Sometimes	Frequently	Always
Apply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved	NeverApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Never	InfrequentlyApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Infrequently	SometimesApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Sometimes	FrequentlyApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Frequently	AlwaysApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Always
Review efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape	NeverReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Never	InfrequentlyReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Infrequently	SometimesReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Sometimes	FrequentlyReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Frequently	AlwaysReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Always
Consider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023	NeverConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Never	InfrequentlyConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Infrequently	SometimesConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Sometimes	FrequentlyConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Frequently	AlwaysConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Always

How often do you intend to implement them AFTER participating? (select all that apply) *

	Never	Infrequently	Sometimes	Frequently	Always
Apply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved	NeverApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Never	InfrequentlyApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Infrequently	SometimesApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Sometimes	FrequentlyApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Frequently	AlwaysApply guidelines or best practices in order to prevent COVID-19 infection for individuals with CKD as the pandemic has evolved Always
Review efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape	NeverReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Never	InfrequentlyReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Infrequently	SometimesReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Sometimes	FrequentlyReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Frequently	AlwaysReview efficacy and safety data of COVID-19 vaccines and the relationship with the variant landscape Always
Consider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023	NeverConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Never	InfrequentlyConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Infrequently	SometimesConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Sometimes	FrequentlyConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Frequently	AlwaysConsider the impact to COVID-19 vaccinations/ boosters, testing, and treatments once the Federal Public Health Emergency expires in May 2023 Always

Is there information from this activity that was especially helpful or lacking for your patients?